Cronos Group Inc. (CRON.TO)
CAD 2.73
(1.3%)
CAD 2.73
(1.3%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | 2.55 Million USD | -34.13% |
| 2022 | 3.87 Million USD | -60.47% |
| 2021 | 9.8 Million USD | -0.08% |
| 2020 | 9.81 Million USD | 38.09% |
| 2019 | 7.1 Million CAD | -53.8% |
| 2018 | 15.38 Million CAD | 260.41% |
| 2017 | 4.26 Million CAD | 43.42% |
| 2016 | 2.97 Million CAD | 163.88% |
| 2015 | 1.12 Million CAD | 1038.43% |
| 2014 | 99.06 Thousand CAD | 0.0% |
| 2013 | - CAD | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q1 | 2.26 Million USD | -11.36% |
| 2024 Q2 | 1.99 Million USD | -11.93% |
| 2023 Q3 | 2.7 Million USD | -16.16% |
| 2023 FY | 2.55 Million USD | -34.13% |
| 2023 Q1 | 3.53 Million USD | -8.88% |
| 2023 Q2 | 3.22 Million USD | -8.72% |
| 2023 Q4 | 2.55 Million USD | -5.55% |
| 2022 Q3 | 6.89 Million USD | -22.71% |
| 2022 FY | 3.87 Million USD | -60.47% |
| 2022 Q1 | 9.26 Million USD | -5.5% |
| 2022 Q4 | 3.87 Million USD | -43.78% |
| 2022 Q2 | 8.92 Million USD | -3.74% |
| 2021 Q2 | 7.53 Million USD | -19.46% |
| 2021 FY | 9.8 Million USD | -0.08% |
| 2021 Q1 | 9.36 Million USD | -4.62% |
| 2021 Q4 | 9.8 Million USD | -4.81% |
| 2021 Q3 | 10.3 Million USD | 36.65% |
| 2020 Q2 | 10.16 Million USD | -3.3% |
| 2020 Q3 | 9.88 Million USD | -2.74% |
| 2020 Q4 | 9.81 Million USD | -0.73% |
| 2020 FY | 9.81 Million USD | 38.09% |
| 2020 Q1 | 10.51 Million USD | 47.9% |
| 2019 FY | 7.1 Million CAD | -53.8% |
| 2019 Q4 | 7.1 Million CAD | 15.24% |
| 2019 Q3 | 6.16 Million CAD | 129.61% |
| 2019 Q2 | 2.68 Million CAD | 50.49% |
| 2019 Q1 | 1.78 Million CAD | -88.4% |
| 2018 Q4 | 15.38 Million CAD | 247.2% |
| 2018 Q1 | 4.33 Million CAD | 1.49% |
| 2018 FY | 15.38 Million CAD | 260.41% |
| 2018 Q3 | 4.43 Million CAD | 4.7% |
| 2018 Q2 | 4.23 Million CAD | -2.32% |
| 2017 Q3 | 4.74 Million CAD | 0.0% |
| 2017 Q2 | - CAD | -100.0% |
| 2017 FY | 4.26 Million CAD | 43.42% |
| 2017 Q1 | 2.99 Million CAD | 0.79% |
| 2017 Q4 | 4.26 Million CAD | -10.12% |
| 2016 Q2 | 88.88 Thousand CAD | -92.63% |
| 2016 Q4 | 2.97 Million CAD | -2.18% |
| 2016 Q3 | 3.04 Million CAD | 3322.81% |
| 2016 FY | 2.97 Million CAD | 163.88% |
| 2016 Q1 | 1.2 Million CAD | 6.91% |
| 2015 Q3 | 977.39 Thousand CAD | -2.94% |
| 2015 Q1 | 485.09 Thousand CAD | 0.0% |
| 2015 FY | 1.12 Million CAD | 1038.43% |
| 2015 Q4 | 1.12 Million CAD | 15.39% |
| 2015 Q2 | 1 Million CAD | 107.59% |
| 2014 Q3 | - CAD | 0.0% |
| 2014 FY | 99.06 Thousand CAD | 0.0% |
| 2014 Q2 | - CAD | 0.0% |
| 2013 FY | - CAD | 0.0% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| Aurora Cannabis Inc. | 104.79 Million CAD | 97.564% |
| Avicanna Inc. | 1.8 Million CAD | -41.566% |
| Avant Brands Inc. | 18.7 Million CAD | 86.349% |
| Cardiol Therapeutics Inc. | 158.53 Thousand CAD | -1510.4% |
| Crescita Therapeutics Inc. | 1.25 Million CAD | -103.589% |
| Knight Therapeutics Inc. | 69.09 Million CAD | 96.305% |
| MediPharm Labs Corp. | 2.29 Million CAD | -11.242% |
| OrganiGram Holdings Inc. | 155 Thousand CAD | -1547.097% |
| Canopy Growth Corporation | 683.17 Million CAD | 99.626% |
| Willow Biosciences Inc. | 2.15 Million CAD | -18.414% |
| Auxly Cannabis Group Inc. | 159.04 Million CAD | 98.395% |